Purchases and Sales Made in Q1 2024 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q1 2024. The information is specifically focused on institutions that hold shares of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-144K- 17.75% |
$6.3M - $9.19M
|
667K
$26.6M
|
|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-174K- 29.04% |
$7.61M - $11.1M
|
425K
$16.9M
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-178K- 7.7% |
$7.8M - $11.4M
|
2.14M
$85.1M
|
|
|
May 07, 2024
Q1 2024
|
Times Square Capital Management, LLC
|
SELL
|
- |
-279K- 57.14% |
$12.2M - $17.8M
|
209K
$8.35M
|
|
|
Dec 06, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-345K- 84.42% |
$15.1M - $22.1M
|
63.7K
$2.54M
|
|
|
Feb 07, 2025
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-345K- 84.42% |
$15.1M - $22.1M
|
63.7K
$2.54M
|
|
|
May 14, 2024
Q1 2024
|
Finepoint Capital LP
Boston, MA |
SELL
|
- |
-534K- 59.67% |
$23.4M - $34.1M
|
361K
$14.4M
|